Market revenue in 2023 | USD 5.8 million |
Market revenue in 2030 | USD 7.3 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.28% in 2023. Horizon Databook has segmented the Sweden in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden has a well-developed healthcare infrastructure with a strong focus on early disease detection and prevention. This is anticipated to potentially drive the demand for quality control in screening and diagnostic procedures. Like many other developed countries, Sweden has been witnessing an increase in the incidence of chronic conditions.
According to a Swedish Cancer Society Report published in 2023, around 68,810 people were diagnosed with cancer, and by 2040, 100,000 new cancer cases are expected to be detected. This growing patient population may drive the demand for effective diagnostics for early diagnosis and monitoring.
Sweden’s universal health system covers services such as inpatient, outpatient, diagnostics, and prescription drugs. The health system in the country is decentralized and all residents are covered by healthcare services.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Sweden in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account